NCT04892407 - Algeness DF 3.5% Compared to Voluma in Volume Deficit in Mid-face | Biotech Hunter

Enrollment

308

Participants

Timeline

Start Date

September 6, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

August 31, 2024

Conditions

Age-Related Volume Deficit in the Mid-Face

Interventions

DEVICE

Algeness® DF 3.5%

dermal filler CE Mark approved for treatment of cheek and midface volume loss

DEVICE

Juvéderm Voluma

dermal filler CE Mark approved for treatment of cheek and midface volume loss

Trial Locations (9)

RECRUITING

THINKIN, Paris

RECRUITING

J. Vandeputte, Plastische Chirurgie, Oudenaarde

RECRUITING

MEDITI, Antibes

RECRUITING

Rosenpark Research GmbH, Darmstadt

RECRUITING

Private Practice for Dermatology and Aesthetics, Munich

RECRUITING

Shamir Medical Center, Ẕerifin

NOT_YET_RECRUITING

Clique Clinic, Petaling Jaya

RECRUITING

Beauty Beyond Skin (Ocean Clinic Marbella), Marbella

RECRUITING

Galadari Derma Clinic, Dubai